Challenges and strategies in the soluble expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD fusion proteins as candidates for COVID-19 intranasal vaccines.

Autor: Tarigan S; Research Organization for Health, National Research and Innovation (BRIN), Cibinong, Indonesia., Sekarmila G; Research Organization for Health, National Research and Innovation (BRIN), Cibinong, Indonesia., Apas; Research Organization for Health, National Research and Innovation (BRIN), Cibinong, Indonesia., Sumarningsih; Research Organization for Health, National Research and Innovation (BRIN), Cibinong, Indonesia., Tarigan R; School of Veterinary and Medical Sciences, IPB University, Bogor, Indonesia., Putri R; Research Organization for Health, National Research and Innovation (BRIN), Cibinong, Indonesia., Setyawati DR; Research Organization for Health, National Research and Innovation (BRIN), Cibinong, Indonesia.

Publikováno v: PloS one [PLoS One] 2024 Dec 26; Vol. 19 (12), pp. e0306153. Date of Electronic Publication: 2024 Dec 26 (Print Publication: 2024).